Thank you for sharing!

Your article was successfully shared with the contacts you provided.
A lab technician extracts a portion of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand, Monday, May 25, 2020. Researchers in Thailand claim to have promising results with the vaccination on mice, and have begun testing on monkeys. (AP Photo/Sakchai Lalit) Vaccines will be manufactured in a handful of locations and then go through a sprawling infrastructure of transportation and warehouses to get to their final destinations, according to JLL. Complicating that journey will be the different temperature and freezer requirements of the three leading vaccines. (Photo: AP Photo/Sakchai Lalit)

The cold storage asset class has been seeing high levels of investment, but this may not necessarily translate into a smooth supply chain for the distribution of COVID-19 vaccines. The answer, experts say, may be a mix of strategies for distributing the vaccine.


Join PropertyCasualty360

Don’t miss crucial news and insights you need to make informed decisions for your P&C insurance business. Join PropertyCasualty360.com now!

  • Unlimited access to PropertyCasualty360.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including BenefitsPRO.com, ThinkAdvisor.com and Law.com
  • Exclusive discounts on PropertyCasualty360, National Underwriter, Claims and ALM events

Already have an account? Sign In Now
Join PropertyCasualty360

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.